Operator
Good morning, ladies and gentlemen, and welcome to Chemtrade Logistics Income Fund third quarter 2026 Q&A portion of the conference call. At this time, note that all participant lines are in a listen-only mode.
If anyone has any difficulty hearing the conference, please press *0 for an operator assistance at any time. I would like to turn the conference over to Rohit Bhardwaj, Chief Financial Officer.
Please go ahead.
Rohit Bhardwaj
Thank you, Zoe. Thank you for joining the Q&A session of Chemtrade's third quarter 2026 results.
Our press release, financial statements, presentation, and prepared remarks have been posted on our Investor Relations website at chemtradelogistics.com. Before we proceed, I would like to remind everyone that today's call will contain certain forward-looking statements that are based on current expectations and are subject to a number of risks and uncertainties.
Actual results may differ materially from those expressed or implied. Additional information regarding these risks, uncertainties, and assumptions, as well as information on certain non-IFRS and other financial measures referred to today, can be found in our disclosure documents filed with the securities regulators and available on sedarplus.com.
One of the non-IFRS measures we will refer to today is adjusted EBITDA, which is EBITDA modified to exclude non-cash items such as unrealized foreign exchange gains and losses. While our slide deck and disclosure documents refer to adjusted EBITDA, we may refer to it as EBITDA during the call.
With that, we would now like to open up the lines for your questions. Thank you.
Operator?
Operator
Thank you. Ladies and gentlemen, if you do have any questions, please press * followed by 1 on your touchtone phone.
You will hear a prompt that your hand has been raised. Should you wish to decline from the polling process, please press * followed by 2.
If on a speakerphone, you will need to lift the handset first before pressing any keys. Please go ahead and press *1 now if you have any questions.
Thank you. Your first question will be from Joel Jackson at BMO Capital Markets.
Please go ahead.
Joel Jackson
Hi. Good morning, everyone.
I know it's a little early for '27. I was wondering if you guys can give us a little bit of high-level puts and takes on the three businesses and corporate costs directionally, higher, lower, neutral, '27.
What we should expect for the businesses and corporate costs relative to '26?
Scott Rook
Hey, Joel. Good morning.
This is Scott. Sure.
I'll start with water chemicals, and I'll say that the biggest impact on the water business we believe for next year will be the impact of sulfur. We've already seen sulfur prices drop and our anticipation is that sulfur is going to be lower in '27, and so I think that's going to have a positive impact on the water business next year.
Obviously, how much so will depend on the impact of sulfur. As you and others are aware, in water, we price our water treatment chemicals at a fixed price for the year.
Sulfur is a major component of that, and so our team has been raising price all year long tied to sulfur, and those prices now are good for one year. As sulfur drops, that will benefit the business.
Then secondly, in water, we have continued to invest in our organic growth projects, and so next year we'll see the full-year benefit of those organic growth projects. When it comes to acid, we'll see on the regen side continued strength in the business, sort of might see a bit of an uptick in volume, but basically steady and strong, and so that's positive.
We'll see a pickup in ultrapure relative to the other businesses. It'll be modest, but definitely a pickup.
I've shared that we have two qualifications now, we're very happy to report, and we're working on others. A little uptick in ultrapure.
Then with merchant acid, we'll probably see some moderation in merchant acid as sulfur prices decline. Then in electrochem, number one, we will not have a turnaround next year, so that's positive.
There's a lot of uncertainty in caustic. We know that CMA is forecasting for caustic prices to rise, but that'll be a nice thing, but it's unknown right now.
Chlorine, probably continued weakness. Don't see a lot of movement up or down in chlorine, and hydrochloric will be a function of fracking activity.
To the extent that's strong, that'll be a pickup there. Those are the major pieces, I think, that'll have an impact on our business next year.
Rohit Bhardwaj
I think on the corporate side, as you asked, we we expect it to be, somewhat flat. We aren't expecting any any big changes from year to year, from this year to next year.
2025, as corporate costs were were very high because we had the big run-up in the in the unit price, and obviously, if there's another big run-up, that'd be a nice thing to to to have, but other than that, we don't expect much of a difference.
Joel Jackson
Okay. Then my second question before I pass the baton here would be, we all know what's happened with North Van with the approvals.
Can you update on one of the lawsuits I think that is going forward and any timelines, expectations? I know it is a public forum, but anything you can provide the market to what we should expect?
Scott Rook
Sure, can. There has been a judicial review that's been filed against the District of North Vancouver.
Chemtrade are not named in that judicial review. We are assisting the District, though, in that process.
We don't have a lot of specifics, but I can share that we are anticipating that will go in front of a judge around mid-year next year. Then after the judge hears the case, then the judge would have three to four months to write a decision and make that public.
That's the timing of what we're saying. Going in front of a judge maybe mid-year plus or minus a few months and then three or four months for a decision.
Joel Jackson
Just follow up on that, and I'll go. Sorry.
That would mean I know you've talked about having the big CapEx there around safety and liquefaction in 2028 and 2030. You talk about a year here, but would that impact your '28 prior disclosures for your '28 plans, or is it right on pace?
Scott Rook
I would say it would be consistent with that we could still execute our '28 plans. Might have an impact.
In '27, there are some pieces of equipment that we would basically order in advance, some long lead time items, and so we'd have to check on that, which we're all already working on that to see if we would feel comfortable ordering advanced long lead time items next year. Basically, as you're right, in our plan, we had scheduled to do the majority of the work in '28 and in '30, and so tie it into two two of the biannual turnarounds.
Joel Jackson
Okay. Thank you.
Operator
Next question comes from Himir Patel at CIBC Capital Markets. Please go ahead.
Himir Patel
Hi. Good morning.
Just following up on that earlier question. Appreciate all the product details, Scott, you provided about 2027.
When you put all those pieces together, would that suggest arrow up for EBITDA next year?
Scott Rook
Basically, yeah, I think, Himir. I won't comment on the magnitude of the arrow up because we'll be releasing the magnitude of the arrow up in January.
Generally, yes, I think that points to an arrow up next year.
Himir Patel
Great. Thanks.
Scott, on the ultrapure side, you referenced you're going through qualifications with I think two of the other four large semiconductor manufacturers. Any sense as to timing of when that process will likely complete?
Scott Rook
Great question, and so it's hard to say. Hard to say.
Probably don't want to answer specific because we're involved in that process. I would just say we're working very, very closely with those OEMs and with samples and working on approval process.
We are planning on more approvals, I'll just say, in 2027. As the other two are ramping up their volume, we're expecting more approvals to come in, I'll just leave it at that.
Is that all right?
Rohit Bhardwaj
I just add, using your arrow-up comment, for ultrapure, we definitely expect the arrow to be up in '27 versus '26. The actual ramp will depend on how quickly these things happen.
We are expecting upward movement from our contribution margin perspective.
Himir Patel
Okay. Fair enough.
Thanks. I'll turn it over.
Operator
Next question comes from Ben Isaacson at Scotiabank. Please go ahead.
Ben Isaacson
Thank you very much, and good morning. Thank you for going straight to Q&A.
It's a great best practice. I have two questions.
The first question is on your segments. If you were to assume bottom of the cycle commodity prices or margins, are each of those businesses free cash flow neutral or positive?
Is that an ambition of yours if they're not? Can you just talk about that?
Thank you.
Rohit Bhardwaj
Yes. I'll give you the answer first, but I'll give you a bit of color afterwards.
The answer is absolutely no, not even close to not being on the positive side. I think when you look at the segments, the ASP segment doesn't tend to have the full effect of cyclicality because merchant acid is structured with risk-shared contracts.
It dampens the ups and downs. On the regen side, if you look at refinery operating rates, they really don't cycle very much in the sense that even in a recession, the demand is very resilient because people still drive a lot, and you may get a couple percent impact on refinery utilization rates.
Given the nature of our contracts that are long-term and really pass through of all costs with potential for margin improvement as contracts roll over. That segment, you really don't worry too much about cyclicality.
On the water side, there is a bit of a cyclical impact, which is countercyclical because we have one year fixed-price selling prices and costs can go up and down. If you look at it over a cycle, once costs start to come down, we actually improve margins.
Again, not even close to being worried about it not being positive. Then you've seen chlor-alkali.
You've seen our assumptions. A good example is 2026.
We are saying we're expecting our MECUs to be down by almost $285 an MECU, and you're still seeing the numbers we're putting out. I think it's very hard to argue that we're not at or very close to the bottom, given where North Asia caustic is at $300.
That's a little bit of more color for you, but I don't want to just give the answer as yes or no because I want to give you the answer that there's a huge buffer in the business, and that's not something to worry about.
Ben Isaacson
That's super helpful. Thank you, Rohit.
Then just my second question. I guess I want to ask Joel's question in a different way.
If there were no changes to commodity prices, or even to margins, do each of your segments have a little bit of volume growth next year? Or is that not the case?
Scott Rook
I'll I'll comment on that, and I would say no. If if we look at chlorate, which goes into the pulp and paper, we we are not seeing volumes in pulp and paper increase.
In fact, we we continue to see, slight volume reductions year year-over-year in chlorate, and so we'll anticipate that even as we go into into next year. With with North Vancouver, with our chlor-alkali plant, we take a turnaround every other year, but other than that, we see caustic volumes We run the plant close to capacity.
Our caustic volumes are relatively stable because we're running close to to capacity. Then we can we can shift our chlorine between chlorine and hydrochloric.
Our preference is to sell as much hydrochloric I've said that many times before preference is to sell as much hydrochloric into the fracking industry as we can, and then and then we sell chlorine after that. Let's see.
What else? I think that covers that.
Volume growth for sure in water. Then and then yeah.
Modest in regen, modest in in merchant, and then ultrapure volumes will be up.
Rohit Bhardwaj
I'll just add one thing to that is, just to pick up on what Scott was saying, there's a potential for favorable mix. If fracking starts to get stronger, then we could shift chlorine into HCl.
Even though the overall volume stayed the same, it's beneficial. Even the water treatment, we are focusing a lot on some of the more specialized chemistries.
Again there, even if overall volume doesn't grow that much, we can pick up some margin on the higher-end products that we're trying to invest more in.
Ben Isaacson
Great. Thanks so much.
I'll pass it on.
Operator
Next question comes from Frédéric Tremblay at Desjardins. Please go ahead.
Frédéric Tremblay
Morning. Thanks for taking the questions.
As the $75 to $125 million North Vancouver program ramps starting in the coming years, should we expect any meaningful trade-off with growth capital acquisitions, buybacks, or potential distribution growth? Just curious how you think about capital allocation then.
Scott Rook
Good question. What governs us with that is basically our overall strategy for Vision 2030, which is to grow our earnings and to keep our leverage roughly at the 2.5 target level.
That 75 to 125 is a number that will be spread out between now and 2030. That's not going to be spent all in one year.
To spread it out over four, possibly five years, it's a relatively modest number. What will govern us, if you will, is making sure that we're delivering the earnings and our earnings growth that we've targeted, as well as our leverage.
We intend to continue with the NCIB and continue to invest in organic growth, but we'll let our leverage guide us in terms of the magnitude.
Frédéric Tremblay
Perfect. Thanks for that.
I wanted to ask about the potential M&A, specifically in water following Polychem. What sort of capabilities or geographies are you most interested in in terms of the water solutions segment?
How should we think about valuation thresholds for potential M&A going forward?
Scott Rook
All right. Yes, our strategy has been clear that we want to grow our earnings 5% to 10% per year.
From when we announced that a year and a half ago, we said that as we're moving towards our target, roughly half of our growth we would expect it to come from our organic growth investments and the other half would come from our acquisitions. Our acquisitions, they have been and will continue to be targeted in water treatment space.
We're already a very strong producer in inorganic coagulants. We made two acquisitions in well, two acquisitions in water last year.
One was in coagulants, that was a smaller one, and then we bought Polychem, which was more service. As we look to future acquisitions, we have a very strong position supplying city municipalities all across North America, Canada and the US.
We'd like that position. I could see us continuing to add some new products to our portfolio, if you will, but focused in on our strong position to city municipalities.
We also like the service space, which is where Polychem sits, I think we could be looking at both of those. There are a number of different chemistries that are different than the ones we produce.
There are a number of different chemistries that we could look at that we continue to look at in adding to our portfolio.
Frédéric Tremblay
Thanks very much. I'll pass the line.
Operator
Next question comes from Zachary Evershed at National Bank. Please go ahead.
Zachary Evershed
Good morning, everyone. Thanks for taking my questions.
Scott Rook
Sure.
Zachary Evershed
Compared to the assumptions at the start of the year, electrochemical pricing obviously a good deal weaker, but you were still able to keep the same guidance midpoint. Strength versus your initial assumptions mainly in acid or in water?
Rohit Bhardwaj
I can answer that. Basically, it's really coming from the ASP segment.
Merchant acid has been performing really well. When sulfur goes up, we are able to pass through those costs and pick up a little bit additional, because some of our product is not generated by burning sulfur, but as a byproduct.
It's really coming from that side. I think as you see, our corporate costs are down quite a bit from where they were last year as well.
Zachary Evershed
Got you. Thanks.
Then obviously, we see the CMA forecasts. How do you square those industry forecasts for caustic pricing versus the behavior of producers out of Asia?
Can you reconcile that outlook with the reality of pricing you're seeing today?
Scott Rook
I'll take that one. There's just a lot of volatility.
CMA is forecasting that the caustic soda prices coming out of Asia are going to go up. One of the main reasons that they have that forecast is that roughly 70% of the variable cost to produce caustic soda in Asia is the cost of electricity.
That electricity is coming from natural gas, it's coming from coal, and others. If you look at the cost of electricity coming again, natural gas and coal, those prices are going up.
CMA is looking at that, saying with the input cost up, that has to lead eventually to higher caustic prices. We believe them at some point that's going to happen.
Getting the exact timing of those increases is proven to be difficult. Caustic soda is part of the chlor-alkali, which is tied into PVC, and so China has some different technology for PVC that they have restarted, I guess.
They're running harder than they have the past couple of years, and so that's having an impact. With general construction weakness and other weakness in Asia, that's causing what I hope is temporarily for caustic soda prices to be low.
It's proven to be a very difficult thing to get the timing of changes to be accurate.
Rohit Bhardwaj
I think I just want to add that the belief is that at these current prices in Asia, they're really not sustainable. Either they are at cash cost or even maybe slightly below cash cost.
When you talk to the industry experts, they believe that this is not sustainable at these low prices.
Zachary Evershed
Great color. Thanks.
I'll turn it over.
Operator
Once again, ladies and gentlemen, a reminder to please press *1 should you have any questions. Thank you.
Next will be Steve Hansen at Raymond James. Please go ahead.
Steve Hansen
Good morning, guys. Thanks for the time.
I wanted to turn back to chlor-alkali or EC. I think you've already described a few different of the puts and takes out there, but I'm just curious how the netback economics have shifted over the last two, three years as we've dealt with lower caustic prices, even chlorine starting to drift a little bit.
Doesn't feel like the netbacks have suffered that much, and maybe just help us understand a bit better just how you've been able to protect those netbacks and how the economics have shifted within the different product sets. Thanks.
Scott Rook
Yes. Look, I'll make some comments, Rohit can come in with more details and specific.
Look, we've seen caustic soda, even if we go back before COVID, it was really low, and then after COVID, we saw caustic soda prices jump up to 700. They moderated down into the 350 to 400 range, and over the last quarter or so, they have been below 350, and so that's bounced around quite a bit.
We have seen chlorine prices moderate over the past couple of years, but as chlorine has moderated, we've seen hydrochloric acid increase. There's been both increased demand and increased pricing for hydrochloric acid, all tied into fracking activity.
I think those are the movers. Then we also we focus a lot on operational excellence at all of the Chemtrade plants.
That's a key part of us. We've had productivity projects, reliability projects, and so we keep a very close eye on that, and that's helped us as well.
Rohit Bhardwaj
I'll just add a few comments. If you look at our commentary, we say that in Q3, 95% of the decline in the MECU was led by chlorine and HCl and not by caustic, and year to date, it's 80% with chlorine and HCl.
What's happening with the caustic side is two things. One is, it's a lot more expensive to ship caustic across the ocean, and so we obviously get the benefit of that.
The other thing, our commercial team is doing a very good job is really trying to decouple kind of domestic pricing with the index. Now the index is always going to be there.
Can't ignore it. Our team is looking to see how the dynamics can be shifting towards more domestic-led pricing as opposed to just defaulting to the index.
Those are things that have also benefited us quite a bit when you look at the last couple years.
Steve Hansen
That's helpful. Thanks.
Just wanted to jump over to ultrapure. It's been a process that's taken time.
I think you've described it already. You've got two commercial customers shipping now, more to come in '27.
There's also been a lot of development in the broader landscape here domestically since you first announced the expansion. I just wanted to go back to the idea of where a greenfield opportunity might exist, if ever, versus again maybe another brownfield expansion in the future, just looking at all the capacity that continues to evolve between your facility, Terafab, and others.
It sounds like that demand is continued to improve here pretty markedly. Just want to understand how you're going to evolve with that landscape from here.
Thanks.
Scott Rook
Hey, no, great question. After two to three years of more modest Well, I'll say that there was construction of the fabs, but the fabs did not come on at the rate, I'll say, that the industry was expecting if you go back three to four years ago.
Now, if you move to where we are today, that is not true. Now the fabs are coming online, and they're coming online rather quickly.
If we look out over the next 10 years, the expansions that already have steel in the ground, already under construction, there's significant, significant fabs. That's really not even counting the Terafab, which could come on, which is a whole nother significant add.
We are looking at it closely. We're spending a lot of time looking at it, and so we will continue to look at adding capacity at our sites, but we're also beginning to look and to ask ourselves, what would we need to be convinced of in order to restart, let's say, our efforts out in Arizona?
I wouldn't read too much into that. I just wanted to say we're spending a lot of time working at it, and we think there's definitely market opportunity for a greenfield plant.
Steve Hansen
Maybe just a little follow-up for me, squeeze it in just because I'm curious, is I think one of the hesitations in the past was sort of the CapEx sort of intensity fears and the willingness maybe of those customers to pay for that. With the CapEx dollars flowing today, do you think the environment has shifted sufficiently such that they value that domestic supply chain and are willing to help pay or compensate suppliers to invest the capital or take the risk?
Is that shifted that sentiment, given the AI push and everything else going on?
Scott Rook
I think it is beginning to shift. I would say that it's not completely there, but I will say 100% of the fabs strongly, and I'll just say they strongly want domestic supply for sulfuric acid.
They do believe that the suppliers, particularly in Taiwan and Korea, have world-class quality, but I will share with you, I'll just say we're being told that the quality of acid is also world-class coming out of our plants, and so it's very encouraging.
Steve Hansen
Very good. Appreciate the color.
Thanks.
Scott Rook
Yep.
Operator
Thank you. At this time, we have no other questions registered.
I would like to turn the call over to Scott Rook.
Scott Rook
All right. Listen, I'd like to say thank you to everyone for joining the call.
I'd like to thank all of our employees for their continued hard work and great results, and wish everyone a great rest of the day. Thank you.
Bye.
Operator
Thank you, sir. Ladies and gentlemen, this does indeed conclude the conference call for today.
Once again, thank you for attending. At this time, we do ask that you please disconnect your line.
Already premium?